A diagnostic pitfall in iron-refractory microcytic hypochromic anemia with acquired ring sideroblasts initially treated as iron deficiency anemia—a case report

• by Xiaoqi Liu, Juning Ma, Anning Song, Sheng Yang, Mingxia Li, Jing Yang

• June 8, 2026

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

• December 17, 2025

• 4 min

Prior antibiotics exposure predicts early and prolonged CD19 CAR T-cell-related hematologic toxicity and prognosis in acute B-cell leukemia

• by Jiachen Liu, Yingying Li, Feng Zhu, Bin Lv, Jia Xu, Mengyi Du, Kailin Xu, Heng Mei

• April 7, 2025

Surgical Intervention for Emphysematous Osteomyelitis of the Spine in a Patient with Malnutrition and Anemia: A Unique Case Study

• by Junyu Zhang, Siqi Feng, Zhiqiang Liu, Kan Xie, Chunli Gu, Jun Shen, Yangbo Zhang, Yunlong Zhou

• January 19, 2026